Don’t know what you’re doing? Get the Killing BV guide and learn exactly how to use Fluomizin effectively. Recommended 2 packs – save $5 per pack when you buy two or more.

Fluomizin is a broad-spectrum non-antibiotic non-drug antimicrobial (dequalinium chloride) used widely in Europe to treat vaginal dysbiosis, bacterial vaginosis and aerobic vaginitis.

6 x 10mg dequalinium chloride vaginal tablets

Used for mystery infections/imbalances
One-per-night vaginal dose for 6 – 12 nights for BV/AV
Non-toxic, safe in pregnancy and breastfeeding/nursing
Effective against a range of BV and AV-causing microbes and yeasts
Non-antibiotic, non resistance-forming

Fluomizin^®10 mg vaginal tablets

Note: Product may arrive in a foreign language! Fluomizin is a German product; however, we source Fluomizin from a variety of countries. For the English insert, please download the Fluomizin Information Booklet (PDF).

Dequalinium chloride

Dequalinium chloride, the active ingredient in Fluomizin, is an anti-infective and antiseptic drug, active against some of the bacteria that cause bacterial vaginosis. Fluomizin is used to treat bacterial vaginosis, inserted into the vagina each night for six nights or as recommended by your healthcare provider.

Do not use Fluomizin if:

You are allergic to dequalinium chloride or any of the other ingredients in the tablets
You have vaginal or cervical ulcers
You have never had a menstrual period

Warnings and precautions

Avoid intravaginal soap, spermicides and vaginal douches during treatment with Fluomizin.
Unprotected sex while using Fluomizin or when you have bacterial vaginosis is not recommended.
Fluomizin is safe to use with latex condoms but may reduce the effectiveness of non-latex condoms or diaphragms. Use alternative methods of contraception for at least 12 hours following treatment.
Stop using Fluomizin vaginally if you have heavy menstrual bleeding, and resume after your heavy flow is finished.
If symptoms persist after treatment, you may have bacteria that is unaffected by Fluomizin, and you should be thoroughly PCR tested by your doctor and seek other appropriate treatment.
Fluomizin is unlikely to affect your ability to operate a motor vehicle.

Fluomizin use in children, teenagers and adults over age 55

There is insufficient experience in the use of Fluomizin in children or adolescents under 18 years of age and adults above the age of 55.

Pregnancy and breastfeeding

Talk to your doctor or pharmacist before using Fluomizin if you are pregnant or breastfeeding for personal advice. Fluomizin is considered safe during pregnancy and breastfeeding because it is poorly absorbed into the bloodstream.

Recommended dose

The recommended dose of Fluomizin is one tablet inserted deep into the vagina before bed each day for six days or as prescribed by your healthcare provider.

Instructions for using Fluomizin vaginally

Insert every evening before bed
Wash your hands before opening blister pack and removing the tablet
Lie down with legs slightly bent, and using a clean finger, insert one vaginal tablet deeply.
Don’t use Fluomizin during heavy menstrual bleeding – wait until it’s finished, and then resume use.
Do not stop treatment early even if symptoms abate. Fewer than six days of treatments may result in treatment failure.
Fluomizin ingredients do not dissolve completely and the remainder may, with gravity, appear in your underwear. This is normal and does not affect the effectiveness of the treatment. The tablets do not stain, but you may want to use a panty liner or pad during use.
The tablet needs moisture to dissolve, so if your vagina is dry, put a drop of water onto the tablet before insertion.

What to do if you use too much Fluomizin or forget a dose

You run the risk of vaginal irritation and ulcerations if you use more than the recommended dose of Fluomizin. Do not double the dose if you forget a dose.

Possible side-effects of Fluomizin

Burning and itching, which can be worse at the start of treatment, but usually starts to get better with further treatments. Continue the treatment.
Vaginal discharge (1 in 10 people)
Vaginal yeast infection (thrush) (1 in 10 people)
Vaginal bleeding and pain (1 in 100 people)
Vulvovaginitis (1 in 100 people)
Bacterial vaginosis (1 in 100 people)
Fungal skin infections (1 in 100 people)
Headache (1 in 100 people)
Nausea (1 in 100 people)
Vaginal ulcerations, particularly if the vagina was already damaged prior to treatment (frequency not known)
Uterine bleeding (frequency not known)
Vaginal redness (frequency not known)
Vaginal bleeding (frequency not known)
Bladder inflammation (frequency not known)
Allergic reaction (rash, swelling, itching) (frequency not known)
Fever (frequency not known)